BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19436694)

  • 1. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
    Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
    Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E; Bjermer L; Ekberg M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease.
    Zhang M; Li Q; Zhang XY; Ding X; Zhu D; Zhou X
    Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1487-93. PubMed ID: 20725845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
    Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
    Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.
    Wen Y; Reid DW; Zhang D; Ward C; Wood-Baker R; Walters EH
    Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():327-34. PubMed ID: 21037956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
    Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?
    Andelid K; Tengvall S; Andersson A; Levänen B; Christenson K; Jirholt P; Åhrén C; Qvarfordt I; Ekberg-Jansson A; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():689-702. PubMed ID: 25848245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.
    Andelid K; Andersson A; Yoshihara S; Åhrén C; Jirholt P; Ekberg-Jansson A; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1253-63. PubMed ID: 26170654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease.
    Zanini A; Cherubino F; Zampogna E; Croce S; Pignatti P; Spanevello A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1155-61. PubMed ID: 26124655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory biomarkers in sputum predict COPD exacerbations.
    Tufvesson E; Ekberg M; Bjermer L
    Lung; 2013 Aug; 191(4):413-6. PubMed ID: 23689877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.
    Bafadhel M; Haldar K; Barker B; Patel H; Mistry V; Barer MR; Pavord ID; Brightling CE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1075-83. PubMed ID: 26089657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis.
    Gompertz S; O'Brien C; Bayley DL; Hill SL; Stockley RA
    Eur Respir J; 2001 Jun; 17(6):1112-9. PubMed ID: 11491152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.
    Patel IS; Seemungal TA; Wilks M; Lloyd-Owen SJ; Donaldson GC; Wedzicha JA
    Thorax; 2002 Sep; 57(9):759-64. PubMed ID: 12200518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of tumor necrosis factor-alpha, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease.
    Ko FW; Leung TF; Wong GW; Ngai J; To KW; Ng S; Hui DS
    Int J Chron Obstruct Pulmon Dis; 2009; 4():79-86. PubMed ID: 19436689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Wrona C; Eschberger K; Lobbins P; Cai X; Murphy TF
    Am J Respir Crit Care Med; 2008 Mar; 177(5):491-7. PubMed ID: 18079493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.
    Tangedal S; Aanerud M; Persson LJ; Brokstad KA; Bakke PS; Eagan TM
    Respir Res; 2014 Nov; 15(1):138. PubMed ID: 25398249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
    Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
    Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.